C4 Therapeutics (CCCC) EPS (Basic) Growth (5y) (2024 - 2026)
Powered by 
Analysis
C4 Therapeutics (CCCC) EPS (Basic) Growth (5y) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn |
| 10 | C4 Therapeutics | 495.99 Mn | 242.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.88% |
| Mar 31, 2026 | 16.35% |
| Dec 31, 2025 | 24.56% |
| Sep 30, 2025 | 52.09% |
| Jun 30, 2025 | 47.60% |
| Mar 31, 2025 | 47.80% |
| Dec 31, 2024 | 41.55% |
| Sep 30, 2024 | 45.45% |